BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6454336)

  • 1. Suppressor cell activity in patients with rheumatoid arthritis.
    Smolen JS; Lanzer G; Scherak O; Menzel EJ; Steffen C; Knapp W
    Agents Actions Suppl; 1980; 7():204-7. PubMed ID: 6454336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor T cell dysfunction and anti-suppressor cell antibody in active early rheumatoid arthritis.
    Abdou NI; Lindsley HB; Racela LS; Pascual E; Hassanein KM
    J Rheumatol; 1981; 8(1):9-18. PubMed ID: 6452523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased suppressive B cell factor (SBF) in rheumatoid arthritis: evidence for a defect in B cell autoregulation.
    White RE; Pisko EJ; Foster SL; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2151-7. PubMed ID: 3485142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.
    Meijer CJ; Cnossen J; Lafeber GJ; Damsteeg MJ; Cats A
    Clin Exp Immunol; 1982 Feb; 47(2):368-80. PubMed ID: 6978781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific suppressor cells in rheumatoid arthritis. Con A and PHA induced suppressor cell activity.
    Dunne JV; Sengar DP; Pearson D; McKendry RJ; Gardell D
    J Clin Lab Immunol; 1982 Nov; 9(2):99-104. PubMed ID: 6218307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood.
    Lawson CA; Brown AK; Bejarano V; Douglas SH; Burgoyne CH; Greenstein AS; Boylston AW; Emery P; Ponchel F; Isaacs JD
    Rheumatology (Oxford); 2006 Oct; 45(10):1210-7. PubMed ID: 16571607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor cell responses in patients with rheumatoid arthritis: the effect of thymosin.
    Zatz MM; Oliver J; Goldstein AL; Novak C; Jacobs RP
    Thymus; 1984; 6(4):205-18. PubMed ID: 6238454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
    Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
    J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of suppressor T cell function and circulating immune complexes in alcoholic cirrhosis.
    Echevarría S; San Miguel G; Rodríguez de Lope C; Castillo E; Pons Romero F
    Allergol Immunopathol (Madr); 1985; 13(5):405-10. PubMed ID: 2934964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective loss of suppressor T cells in rheumatoid arthritis patients: analysis of peripheral blood lymphocytes by 2-dimensional flow cytometry.
    Goto M; Miyamoto T; Nishioka K; Okumura K
    J Rheumatol; 1986 Oct; 13(5):853-7. PubMed ID: 2950232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell subsets in patients with rheumatoid arthritis: reduction of cells with Leu 2A phenotype in patients with serum IgG immunocomplexes.
    Queiros MV; Rocha B
    Clin Exp Immunol; 1983 Nov; 54(2):509-14. PubMed ID: 6228352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
    Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
    J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
    Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
    Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immobilized IgG-aggregate-induced cytolytic activity of lymphocytes from patients with rheumatoid arthritis.
    Fuson EW; Whittaker RL; Beard MR
    J Clin Lab Immunol; 1984 Dec; 15(4):181-6. PubMed ID: 6241257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in patients with rheumatoid arthritis: correlation with disease activity.
    Levo Y; Fischel R; Ehrenfeld M
    J Rheumatol; 1981; 8(5):851-5. PubMed ID: 7310781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activity of short-lived suppressor lymphocytes in rheumatoid arthritis].
    Vasil'eva EV; Nasonov EL; Mazneva LM; Saĭkovskiĭ RK; Sura VV
    Ter Arkh; 1985; 57(7):98-102. PubMed ID: 2931852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
    Kao JK; Hsue YT; Lin CY
    J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective IL2 production in active rheumatoid arthritis. Regulation by radiosensitive suppressor cells.
    Cathely G; Amor B; Fournier C
    Clin Rheumatol; 1986 Dec; 5(4):482-92. PubMed ID: 2949912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.